Kerry et al. [18] reported that dual expression of MYC and BCL-2 and BCL-2, MYC, and BCL-6 translocations were associated with a high risk of CNS relapse in DLBCL. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.